“The results show that the majority of U.S. consumers perceive cannabis (as CBD, hemp, marijuana, and THC) as having medical uses and view the potential for abuse of cannabis as less than for commonly prescribed medications and alcohol.”
The post Surve…
Category: Schedule I
NORML Files Amicus Brief to the Supreme Court Challenging Cannabis’ Schedule I Prohibited Status Under Federal Law
“The only resolution to this constitutional conflict is for the Supreme Court to invoke the doctrine of estoppel to prevent the federal government from reversing course and retroactively penalizing that which it has protected in fostering state cannabi…
Federal Judge Dismisses Lawsuit Challenging Marijuana’s Schedule I Prohibited Status
Federal Judge To Hear Arguments Wednesday In Legal Fight Challenging The Constitutionality Of Marijuana’s Illicit Status
A judge for the Federal District Court in Manhattan will hear arguments Wednesday in a lawsuit challenging the constitutionality of federal cannabis prohibition.
DEA Reaffirms Stance That CBD Meets Schedule I Criteria — Reality Says Otherwise
The US Drug Enforcement Administration has publicly reiterated its position that cannabidiol, a non-psychotropic cannabinoid, is properly categorized under federal law as a schedule I controlled substance — meaning that, by definition, it possesses “a high potential for abuse,” “no currently accepted medical use in treatment in the United States,” and lacks “accepted safety … under medical supervision.”
Appeals Court: State-Sanctioned Marijuana Users Not Afforded Second Amendment Rights
Justices for the Ninth Circuit Court of Appeals today ruled in favor of a 1968 federal law prohibiting the sale of firearms to any “unlawful user” of a federally controlled substance.
DEA Reaffirms ‘Flat Earth’ Position With Regard To Marijuana Scheduling
The United States Drug Enforcement Administration has decided to reject a pair of administrative rescheduling petitions challenging the federal classification of cannabis as a Schedule I controlled substance with no accepted medical utility, according to advanced news reports published this evening by NPR, the New York Times, Reuters, and other news outlets.
It Is Time To Deschedule, Not Reschedule, Cannabis
A recent memorandum from the US Drug Enforcement Administration to several United States Senators indicates that the agency is prepared to respond in the coming months to a five-year-old petition seeking to amend the plant’s status as a schedule I prohibited substance. Under the US Controlled Substances Act of 1970, the cannabis plant and its organic cannabinoids are classified as schedule I prohibited substances — the most restrictive category available under the law. As summarized by the DEA, “Schedule I drugs are the most dangerous drugs of all the drug schedules with potentially severe psychological or physical dependence.” Explicitly, substances in this category must meet three specific inclusion criteria: The substance must possess “a high potential for abuse”; it must…
2015: The Year In Review – NORML’s Top 10 Events That Shaped Marijuana Policy
NORML reviews the top news stories of 2015.
NIDA Director Says Cannabidiol Is A “Safe Drug”
The director of the US National Institute on Drug Abuse (NIDA), Nora Volkow, believes that cannabidiol (CBD) – a nonpsychotropic cannabinoid – is “a safe drug with no addictive effects.”